Scholarly publications and presentations by Rochester Regional Health's Infectious Diseases department authors.
Submissions from 2020
2020 Antimicrobial Efficacy, Sean M. Stainton, Rochester Regional Health; Mary Staicu, Rochester Regional Health; and Maryrose Laguio-Vila, Rochester Regional Health
1-1-2020 Comparison of pneumococcal conjugate vaccine (PCV-13) cellular immune responses after primary and booster doses of vaccine, Timothy J. Chapman, Rochester Regional Health; Michael E. Pichichero, Rochester Regional Health; and Ravinder Kaur, Rochester Regional Health
1-1-2020 More is better: influenza vaccines in patients with rheumatoid arthritis, Ann R. Falsey, Rochester Regional Health
Submissions from 2019
8-1-2019 What is the role of rapid molecular testing for seniors and other at-risk adults with respiratory syncytial virus infections?, Steven J. Drews, WMC University of Alberta Hospital, 8440 112th St NW, Edmonton, Alberta, T6J 1L9, Canada., Angela R. Branche, University of Rochester, 601 Elmwood Avenue, Box 689, Rochester, NY 14642, USA., Ann R. Falsey, Rochester Regional Health, et al.
6-21-2019 Mitigating and preventing hepatitis B virus exposures during hemodialysis across a large regional health system, Emil P. Lesho, Rochester Regional Health, John Hix, Rochester Regional Health, Melissa Bronstein, Rochester Regional Health, et al.
3-30-2019 The Slow-Motion Catastrophe of Antimicrobial Resistance and Practical Interventions for All Prescribers, Emil P. Lesho, Rochester Regional Health and Maryrose Laguio-Vila, Rochester Regional Health
Submissions from 2018
12-18-2018 Dialysis Without Borders, Emil Lesho, Rochester Regional Health, John Hix, Rochester Regional Health, Melissa Bronstein, Rochester Regional Health, et al.
11-21-2018 An intervention to control an ICU outbreak of carbapenem-resistant Acinetobacter baumannii: long-term impact for the ICU and hospital, Eli Ben-Chetrit, Infectious Diseases Unit, Shaare Zedek Medical Center, Hebrew University, Jerusalem, Israel., Yonit Wiener-Well, Infectious Diseases Unit, Shaare Zedek Medical Center, Hebrew University, Jerusalem, Israel., Emil Lesho, Rochester Regional Health, et al.
10-1-2018 The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates, Natalie I. Mazur, Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, Netherlands; Department of Paediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, Netherlands., Deborah Higgins, Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Marta C. Nunes, Medical Research Council: Respiratory and Meningeal Pathogens Research Unit and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa; Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, Netherlands., et al.
8-15-2018 Clinical and Genomic Features of the First Cases of Elizabethkingia anophelis Infection in New York, Including the First Case in a Healthy Infant Without Previous Nosocomial Exposure, Erik Snesrud, Multidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, Maryland., Patrick McGann, Multidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, Maryland., Edward Walsh, Department of Medicine, University of Rochester School of Medicine, New York., et al.
7-25-2018 Improving ability of RSV microneutralization assay to detect G-specific and cross-reactive neutralizing antibodies through immortalized cell line selection, M S. Boukhvalova, Sigmovir Biosystems, Inc, 9610 Medical Center Drive, Suite 100, Rockville, MD 20850, USA., A Mbaye, Sigmovir Biosystems, Inc, 9610 Medical Center Drive, Suite 100, Rockville, MD 20850, USA., S Kovtun, Sigmovir Biosystems, Inc, 9610 Medical Center Drive, Suite 100, Rockville, MD 20850, USA., et al.
6-5-2018 Multidrug resistant pathogens respond differently to the presence of co-pathogen, commensal, probiotic and host cells, Agnes P. Chan, J. Craig Venter Institute (JCVI), 9605 Medical Center Drive, Suite 150, Rockville, MD, 20850, United States., Yongwook Choi, J. Craig Venter Institute (JCVI), 9605 Medical Center Drive, Suite 150, Rockville, MD, 20850, United States., Lauren M. Brinkac, J. Craig Venter Institute (JCVI), 9605 Medical Center Drive, Suite 150, Rockville, MD, 20850, United States., et al.
6-1-2018 Got GAS? Ease the Bloat with Real-Time Whole-Genome Sequencing, Emil P. Lesho, Rochester Regional Health, Erik Snesrud, Multidrug-resistant Organism Repository and Surveillance Network,Walter Reed Army Institute of Research,Silver Spring,Maryland., Melissa Bronstein, Rochester Regional Health, et al.
4-1-2018 Semi-Automated Visualization and ANalysis of Trends: A "SAVANT" for Facilitating Antimicrobial Stewardship Using Antistaphylococcal Resistance and Consumption as a Prototype, Robert J. Clifford, Multidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, Maryland., Uzo Chukwuma, EpiData Center Department, Navy and Marine Corps Public Health Center, Portsmouth, Virginia., Michael E. Sparks, Multidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, Maryland., et al.
Submissions from 2017
12-12-2017 An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults, Judith Falloon, MedImmune, Gaithersburg, Maryland., Jing Yu, MedImmune, Gaithersburg, Maryland., Mark T. Esser, MedImmune, Gaithersburg, Maryland., et al.
12-7-2017 Importation, Mitigation, and Genomic Epidemiology of Candida auris at a Large Teaching Hospital, Emil P. Lesho, Rochester Regional Health, Melissa Z. Bronstein, Rochester Regional Health, Patrick McGann, Multidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, Maryland., et al.
11-15-2017 Viral Diagnostics: Only Half the Battle, Angela R. Branche, Department of Medicine, University of Rochester. and Ann R. Falsey, Rochester Regional Health
8-29-2017 Pseudomona s Endocarditis with an unstable phenotype: the challenges of isolate characterization and Carbapenem stewardship with a partial review of the literature, Emil Lesho, Rochester Regional Health, Erik Snesrud, Multidrug-resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, MD USA., Yoon Kwak, Multidrug-resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, MD USA., et al.
7-26-2017 Transcriptomic Biomarkers to Discriminate Bacterial from Nonbacterial Infection in Adults Hospitalized with Respiratory Illness, Soumyaroop Bhattacharya, Division of Neonatology and Pediatric Molecular and Personalized Medicine Program, Department of Pediatrics, University of Rochester School Medicine, Rochester, NY, USA., Alex F. Rosenberg, Division of Allergy Immunology & Rheumatology, Department of Medicine, University of Rochester School Medicine, Rochester, NY, USA., Derick R. Peterson, Department of Biostatistics and Computational Biology, University of Rochester School Medicine, Rochester, NY, USA., et al.
4-1-2017 Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons, Ann R. Falsey, Rochester Regional Health, Christine Koval, Cleveland Clinic, Cleveland, OH, USA., John P. DeVincenzo, Department of Pediatrics and Microbiology, Immunology and Biochemistry, University of Tennessee Center for Health Sciences, Children's Foundation Research Institute at LeBonheur Children's Hospital, Memphis, TN, USA., et al.
Submissions from 2016
1-1-2016 Treatment with novel RSV Ig RI-002 controls viral replication and reduces pulmonary damage in immunocompromised Sigmodon hispidus, M Boukhvalova, Department of Molecular Biology/Virology, Sigmovir Biosystems, Inc., Rockville, MD, USA., J C. Blanco, Department of Molecular Biology/Virology, Sigmovir Biosystems, Inc., Rockville, MD, USA., Ann R. Falsey, Rochester Regional Health, et al.
Submissions from 2015
10-16-2015 Activation of persons living with HIV for treatment, the great study Health behavior, health promotion and society, Kevin Fiscella, University of Rochester Medical Center, Michele Boyd, University of Rochester Medical Center, Julian Brown, Trillium Health, et al.